Advertisement

Orofacial Pain in Patients with Cancer and Mucosal Diseases

  • Noam YaromEmail author
  • Herve Sroussi
  • Sharon Elad
Reference work entry

Abstract

Orofacial pain is an important aspect of cancer, antineoplastic treatment, and oral mucosal diseases. It often serves as the key for diagnosis and the initiation of treatment. Pain management is an essential component of successful treatment of oral manifestations of the underlying disease, and it often serves as the desired primary outcome. Treatment of pain associated with oral mucosal diseases is first and foremost directed at the source of the symptoms rather than pain itself. The clinician should be aware of the importance of pain assessment and consider pain palliation as part of the overall management of the patient’s well-being. This chapter reviews aspects of pain experienced by cancer patients and pain associated with oral cancer and oral mucosal diseases. Also reviewed are the clinical aspects of orofacial pain assessment, monitoring, and management. Finally, this chapter highlights the role of the healthcare provider in early detection of pain syndromes associated with malignancies.

Keywords

Cancer Pain Mucositis Osteonecrosis of the jaw Postsurgical pain Chemotherapy-induced neurotoxicity Breakthrough pain Oral mucosa Recurrent aphthous stomatitis Pemphigus vulgaris Lichen planus 

References

  1. Abdalla-Aslan R, Benoliel R, Sharav Y, Czerninski R. Characterization of pain originating from oral mucosal lesions. Oral Surg Oral Med Oral Pathol Oral Radiol. 2016;121(3):255–61.PubMedCrossRefPubMedCentralGoogle Scholar
  2. Ahmedzai SH, Nauck F, Bar-Sela G, Bosse B, Leyendecker P, Hopp M. A randomized, double-blind, active-controlled, double-dummy, parallel-group study to determine the safety and efficacy of oxycodone/naloxone prolonged-release tablets in patients with moderate/severe, chronic cancer pain. Palliat Med. 2012;26(1):50–60.PubMedPubMedCentralCrossRefGoogle Scholar
  3. Ahmedzai SH, Leppert W, Janecki M, Pakosz A, Lomax M, Duerr H, Hopp M. Long-term safety and efficacy of oxycodone/naloxone prolonged-release tablets in patients with moderate-to-severe chronic cancer pain. Support Care Cancer. 2015;23(3):823–30.PubMedCrossRefPubMedCentralGoogle Scholar
  4. Al-Hashimi I, Schifter M, Lockhart PB, Wray D, Brennan M, Migliorati CA, Axéll T, Bruce AJ, Carpenter W, Eisenberg E, Epstein JB, Holmstrup P, Jontell M, Lozada-Nur F, Nair R, Silverman B, Thongprasom K, Thornhill M, Warnakulasuriya S, van der Waal I. Oral lichen planus and oral lichenoid lesions: diagnostic and therapeutic considerations. Oral Surg Oral Med Oral Pathol Oral Radiol Endod Suppl. 2007;103:S25.e1–12.Google Scholar
  5. Alrashdan MS, Cirillo N, McCullough M. Oral lichen planus: a literature review and update. Arch Dermatol Res. 2016;308(8):539–51.PubMedCrossRefPubMedCentralGoogle Scholar
  6. Arduino PG, Porter SR. Herpes simplex virus type 1 infection: overview on relevant clinico-pathological features. J Oral Pathol Med. 2008;37(2):107–21.PubMedPubMedCentralCrossRefGoogle Scholar
  7. Auret K, Schug SA. Pain management for the cancer patient – current practice and future developments. Best Pract Res Clin Anaesthesiol. 2013;27(4):545–61.PubMedCrossRefPubMedCentralGoogle Scholar
  8. Balasubramaniam R, Kuperstein AS, Stoopler ET. Update on oral herpes virus infections. Dent Clin N Am. 2014;58(2):265–80.PubMedCrossRefPubMedCentralGoogle Scholar
  9. Bassim CW, Fassil H, Mays JW, Edwards D, Baird K, Steinberg SM, Williams KM, Cowen EW, Mitchell SA, Cole K, Taylor T, Avila D, Zhang D, Pulanic D, Grkovic L, Fowler D, Gress RE, Pavletic SZ. Validation of the national institutes of health chronic GVHD oral mucosal score using component-specific measures. Bone Marrow Transplant. 2014;49(1):116–21.PubMedCrossRefPubMedCentralGoogle Scholar
  10. Bassim CW, Fassil H, Mays JW, Edwards D, Baird K, Steinberg SM, Cowen EW, Naik H, Datiles M, Stratton P, Gress RE, Pavletic SZ. Oral disease profiles in chronic graft versus host disease. J Dent Res. 2015;94(4):547–54.PubMedPubMedCentralCrossRefGoogle Scholar
  11. Bellm LA, Epstein JB, Rose-Ped A, Martin P, Fuchs HJ. Patient reports of complications of bone marrow transplantation. Support Care Cancer. 2000;8(1):33–9.PubMedPubMedCentralGoogle Scholar
  12. Benitez-Rosario MA, McDarby G, Doyle R, Fabby C. Chronic cluster-like headache secondary to prolactinoma: uncommon cephalalgia in association with brain tumors. J Pain Symptom Manag. 2009;37(2):271–6.CrossRefGoogle Scholar
  13. Benoliel R, Epstein J, Eliav E, Jurevic R, Elad S. Orofacial pain in cancer: Part I—Mechanisms. J Dent Res. 2007;86:491–505.PubMedCrossRefPubMedCentralGoogle Scholar
  14. Beydoun SR, Shatzmiller RA. Chronic immune-mediated demyelinating polyneuropathy in the setting of cetuximab treatment. Clin Neurol Neurosurg. 2010;112:900–2.PubMedCrossRefPubMedCentralGoogle Scholar
  15. Bindoff LA, Heseltine D. Unilateral facial pain in patients with lung cancer: a referred pain via the vagus? Lancet. 1988;1(8589):812–5.PubMedCrossRefPubMedCentralGoogle Scholar
  16. Boras VV, Savage N. Recurrent aphthous ulcerative disease: presentation and management. Aust Dent J. 2007;52:10–5.CrossRefGoogle Scholar
  17. Bruera E, Paice JA. Cancer pain management: safe and effective use of opioids. In: American society of clinical oncology educational book 2015; 2015. p. e593–9.Google Scholar
  18. Bullitt E, Tew JM, Boyd J. Intracranial tumors in patients with facial pain. J Neurosurg. 1986;64:865–71.PubMedCrossRefPubMedCentralGoogle Scholar
  19. Califf RM, Woodcock J, Ostroff S. A proactive response to prescription opioid abuse. N Engl J Med. 2016;374(15):1480–5.PubMedCrossRefPubMedCentralGoogle Scholar
  20. Capobianco DJ, Brazis PW, Rubino FA, Dalton JN. Occipital condyle syndrome. Headache. 2002;42(2):142–6.PubMedCrossRefPubMedCentralGoogle Scholar
  21. Celentano A, Cirillo N. Desmosomes in disease: a guide for clinicians. Oral Dis. 2017;23(2):157–67.PubMedCrossRefPubMedCentralGoogle Scholar
  22. Chamani G, Rad M, Zarei MR, Lotfi S, Sadeghi M, Ahmadi Z. Efficacy of tacrolimus and clobetasol in the treatment of oral lichen planus: a systematic review and meta-analysis. Int J Dermatol. 2015;54(9):996–1004.PubMedCrossRefPubMedCentralGoogle Scholar
  23. Cheng TM, Cascino TL, Onofrio BM. Comprehensive study of diagnosis and treatment of trigeminal neuralgia secondary to tumors. Neurology. 1993;43:2298–302.PubMedCrossRefPubMedCentralGoogle Scholar
  24. Chwistek M. Recent advances in understanding and managing cancer pain. F1000 Res. 2017;6:945.CrossRefGoogle Scholar
  25. Curtis RE, Rowlings PA, Deeg HJ, Shriner DA, Socíe G, Travis LB, Horowitz MM, Witherspoon RP, Hoover RN, Sobocinski KA, Fraumeni JF Jr, Boice JD Jr. Solid cancers after bone marrow transplantation. N Engl J Med. 1997;336(13):897–904.PubMedCrossRefPubMedCentralGoogle Scholar
  26. Daggett P, Nabarro J. Neurological aspects of insulinomas. Postgrad Med J. 1984;60(707):577–81.PubMedPubMedCentralCrossRefGoogle Scholar
  27. Dahlén G. Bacterial infections of the oral mucosa. Periodontol. 2009;49:13–38.CrossRefGoogle Scholar
  28. Davies AN. Breakthrough cancer pain. Curr Pain Headache Rep. 2014;18(6):420.PubMedCrossRefPubMedCentralGoogle Scholar
  29. Davies AN, Dickman A, Reid C, Stevens AM, Zeppetella G, Science Committee of the Association for Palliative Medicine of Great Britain and Ireland. The management of cancer-related breakthrough pain: recommendations of a task group of the Science Committee of the Association for Palliative Medicine of Great Britain and Ireland. Eur J Pain. 2009;13(4):331–8.PubMedCrossRefPubMedCentralGoogle Scholar
  30. Davies A, Buchanan A, Zeppetella G, Porta-Sales J, Likar R, Weismayr W, Slama O, Korhonen T, Filbet M, Poulain P, Mystakidou K, Ardavanis A, O'Brien T, Wilkinson P, Caraceni A, Zucco F, Zuurmond W, Andersen S, Damkier A, Vejlgaard T, Nauck F, Radbruch L, Sjolund KF, Stenberg M. Breakthrough cancer pain: an observational study of 1000 European oncology patients. J Pain Symptom Manag. 2013;46(5):619–28.CrossRefGoogle Scholar
  31. De Sanctis V, Bossi P, Sanguineti G, Trippa F, Ferrari D, Bacigalupo A, Ripamonti CI, Buglione M, Pergolizzi S, Langendjik JA, Murphy B, Raber-Durlacher J, Russi EG, Lalla RV. Mucositis in head and neck cancer patients treated with radiotherapy and systemic therapies: literature review and consensus statements. Crit Rev Oncol Hematol. 2016;100:147–66.PubMedCrossRefPubMedCentralGoogle Scholar
  32. De Santis S, Borghesi C, Ricciardi S, Giovannoni D, Fulvi A, Migliorino MR, Marcassa C. Analgesic effectiveness and tolerability of oral oxycodone/naloxone and pregabalin in patients with lung cancer and neuropathic pain: an observational analysis. Onco Targets Ther. 2016;9:4043–52.PubMedPubMedCentralCrossRefGoogle Scholar
  33. Des Prez RD, Freemon FR. Facial pain associated with lung cancer: a case report. Headache. 1983;23:43–4.PubMedCrossRefPubMedCentralGoogle Scholar
  34. Dios PD, Lestón JS. Oral cancer pain. Oral Oncol. 2010;46(6):448–51.PubMedCrossRefPubMedCentralGoogle Scholar
  35. Edvardsson B. Cluster headache associated with a clinically non-functioning pituitary adenoma: a case report. J Med Case Rep. 2014;8:451.PubMedPubMedCentralCrossRefGoogle Scholar
  36. Edvardsson B, Persson S. Cluster headache and parietal glioblastoma multiforme. Neurologist. 2012;18(4):206–7.PubMedCrossRefPubMedCentralGoogle Scholar
  37. Elad S, Zadik Y. Chronic oral mucositis after radiotherapy to the head and neck: a new insight. Support Care Cancer. 2016;24(11):4825–30.PubMedCrossRefPubMedCentralGoogle Scholar
  38. Elad S, Galili D, Garfunkel AA, Or R. Thalidomide-induced perioral neuropathy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1997;84:362–4.PubMedCrossRefPubMedCentralGoogle Scholar
  39. Elad S, Or R, Shapira MY, Haviv A, Galili D, Garfunkel AA, Bitan M, Kaufman E. CO2 laser in oral graft-versus-host disease: a pilot study. Bone Marrow Transplant. 2003;32(10):1031–4.PubMedCrossRefPubMedCentralGoogle Scholar
  40. Elad S, Gomori MJ, Ben-Ami N, Friedlander-Barenboim S, Regev E, Lazarovici TS, Yarom N. Bisphosphonate-related osteonecrosis of the jaw: clinical correlations with computerized tomography presentation. Clin Oral Investig. 2010;14(1):43–50.PubMedCrossRefPubMedCentralGoogle Scholar
  41. Epstein JB, Jones CK. Presenting signs and symptoms of nasopharyngeal carcinoma. Oral Surg Oral Med Oral Pathol. 1993;75(1):32–6.PubMedCrossRefPubMedCentralGoogle Scholar
  42. Epstein JB, Elad S, Eliav E, Jurevic R, Benoliel R. Orofacial pain in cancer: part II–clinical perspectives and management. J Dent Res. 2007;86(6):506–18.PubMedCrossRefPubMedCentralGoogle Scholar
  43. Epstein JB, Hong C, Logan RM, Barasch A, Gordon SM, Oberle-Edwards L, McGuire D, Napenas JJ, Elting LS, Spijkervet FK, Brennan MT. A systematic review of orofacial pain in patients receiving cancer therapy. Support Care Cancer. 2010;18(8):1023–31.PubMedCrossRefPubMedCentralGoogle Scholar
  44. Espitalier F, Testelin S, Blanchard D, Binczak M, Bollet M, Calmels P, Couturaud C, Dreyer C, Navez M, Perrichon C, Morinière S, Albert S, SFORL Work Group. Management of somatic pain induced by treatment of head and neck cancer: Postoperative pain. Guidelines of the French Oto-Rhino-Laryngology–Head and Neck Surgery Society (SFORL). Eur Ann Otorhinolaryngol Head Neck Dis. 2014;131(4):249–52.PubMedCrossRefPubMedCentralGoogle Scholar
  45. Fall-Dickson JM, Ramsay ES, Castro K, Woltz P, Sportés C. Oral mucositis-related oropharyngeal pain and correlative tumor necrosis factor-alpha expression in adult oncology patients undergoing hematopoietic stem cell transplantation. Clin Ther. 2007;29(Suppl):2547–61.PubMedCrossRefPubMedCentralGoogle Scholar
  46. Fall-Dickson JM, Mitchell SA, Marden S, Ramsay ES, Guadagnini JP, Wu T, St John L, Pavletic SZ. National institutes of health chronic graft-versus-host disease study group. Oral symptom intensity, health-related quality of life, and correlative salivary cytokines in adult survivors of hematopoietic stem cell transplantation with oral chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2010;16(7):948–56.PubMedPubMedCentralCrossRefGoogle Scholar
  47. Fassil H, Bassim CW, Mays J, Edwards D, Baird K, Steinberg SM, Williams KM, Cowen EW, Mitchell SA, Hakim FT, Taylor T, Avila D, Zhang D, Grkovic L, Datiles M, Gress RE, Pavletic SZ. Oral chronic graft-vs.-host disease characterization using the NIH scale. J Dent Res. 2012;91(7 Suppl):45S–51S.PubMedCrossRefPubMedCentralGoogle Scholar
  48. Firth NA, Rich AM, Reade PC. Oral mucosal ulceration due to cytomegalovirus associated with human immunodeficiency virus infection. Case report and brief review. Aust Dent J. 1994;39(5):273–5.PubMedCrossRefPubMedCentralGoogle Scholar
  49. Fischer DJ, Epstein JB. Management of patients who have undergone head and neck cancer therapy. Dent Clin N Am. 2008;52:39–60.PubMedCrossRefPubMedCentralGoogle Scholar
  50. Gellrich NC, Schimming R, Schramm A, Schmalohr D, Bremerich A, Kugler J. Pain, function, and psychologic outcome before, during, and after intraoral tumor resection. J Oral Maxillofac Surg. 2002;60(7):772–7.PubMedCrossRefPubMedCentralGoogle Scholar
  51. Gorsky M, Epstein JB, Oakley C, Le ND, Hay J, Stevenson-Moore P. Carcinoma of the tongue: a case series analysis of clinical presentation, risk factors, staging, and outcome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004;98(5):546–52.PubMedCrossRefPubMedCentralGoogle Scholar
  52. Gracely RH. Measuring pain in the clinic. Anesth Prog. 1990;37(2–3):88–92.PubMedPubMedCentralGoogle Scholar
  53. Grinde B. Herpesviruses: latency and reactivation – viral strategies and host response. J Oral Microbiol. 2013;5:22766.CrossRefGoogle Scholar
  54. Heinic GS, Greenspan D, Greenspan JS. Oral CMV lesions and the HIV infected. Early recognition can help prevent morbidity. J Am Dent Assoc. 1993;124(2):99–105.PubMedCrossRefPubMedCentralGoogle Scholar
  55. Heir GM, Masterson M. Bilateral glossopharyngeal neuropathy following chemo and radiation therapy for a primitive neuroectodermal tumour. J Oral Rehabil. 2016;43(2):154–8.PubMedCrossRefPubMedCentralGoogle Scholar
  56. Hjermstad MJ, Kaasa S, Caraceni A, Loge JH, Pedersen T, Haugen DF, Aass N. European Palliative Care Research Collaborative (EPCRC). Characteristics of breakthrough cancer pain and its influence on quality of life in an international cohort of patients with cancer. BMJ Support Palliat Care. 2016;6(3):344–52.PubMedCrossRefPubMedCentralGoogle Scholar
  57. Imanguli MM, Alevizos I, Brown R, Pavletic SZ, Atkinson JC. Oral graft-versus-host disease. Oral Dis. 2008;14(5):396–412.PubMedPubMedCentralCrossRefGoogle Scholar
  58. Ismail SB, Kumar SK, Zain RB. Oral lichen planus and lichenoid reactions: etiopathogenesis, diagnosis, management and malignant transformation. J Oral Sci. 2007;49:89–106.PubMedCrossRefPubMedCentralGoogle Scholar
  59. Jandhyala R, Fullarton JR, Bennett MI. Efficacy of rapid-onset oral fentanyl formulations vs. oral morphine for cancer-related breakthrough pain: a meta-analysis of comparative trials. J Pain Symptom Manag. 2013;46(4):573–80.CrossRefGoogle Scholar
  60. Kamsvåg-Magnusson T, Thorsell-Cederberg J, Svanberg A, von Essen L, Arvidson J, Mellgren K, Toporski J, Ljungman G. Parents and children's perceptions of distress related to oral mucositis during haematopoietic stem cell transplantation. Acta Paediatr. 2014;103(6):630–6.PubMedPubMedCentralCrossRefGoogle Scholar
  61. Kanas RJ, Jensen JL, Abrams AM, Wuerker RB. Oral mucosal cytomegalovirus as a manifestation of the acquired immune deficiency syndrome. Oral Surg Oral Med Oral Pathol. 1987;64(2):183–9.PubMedCrossRefPubMedCentralGoogle Scholar
  62. Kaplan I, Hodak E, Ackerman L, Mimouni D, Anhalt GJ, Calderon S. Oral Oncol. 2004;40(6):553–62.PubMedCrossRefPubMedCentralGoogle Scholar
  63. Kolokotronis A, Louloudiadis K, Fotiou G, Matiais A. Oral manifestations of infections of infections due to varicella zoster virus in otherwise healthy children. J Clin Pediatr Dent. 2001;25(2):107–12.PubMedCrossRefPubMedCentralGoogle Scholar
  64. Kurnatowski P, Moqbil S, Kaczmarczyk D. Signs, symptoms and the prevalence of fungi detected from the oral cavity and pharynx of radiotherapy subjects with head and neck tumors, and their susceptibility to chemotherapeutics. Ann Parasitol. 2014;60(3):207–13.PubMedPubMedCentralGoogle Scholar
  65. Lalla RV, Bowen J, Barasch A, Elting L, Epstein J, Keefe DM, McGuire DB, Migliorati C, Nicolatou-Galitis O, Peterson DE, Raber-Durlacher JE, Sonis ST, Elad S. Mucositis Guidelines Leadership Group of the Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology (MASCC/ISOO). MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer. 2014;120(10):1453–61.PubMedPubMedCentralCrossRefGoogle Scholar
  66. Lam DK, Schmidt BL. Orofacial pain onset predicts transition to head and neck cancer. Pain. 2011;152(5):1206–9.PubMedPubMedCentralCrossRefGoogle Scholar
  67. Lazarovici TS, Yahalom R, Taicher S, Elad S, Hardan I, Yarom N. Bisphosphonate-related osteonecrosis of the jaws: a single-center study of 101 patients. J Oral Maxillofac Surg. 2009;67(4):850–5.PubMedCrossRefPubMedCentralGoogle Scholar
  68. Le Cleach L, Chosidow O. Lichen planus. N Engl J Med. 2012;366:723–32.PubMedCrossRefPubMedCentralGoogle Scholar
  69. Lee J, Bloom R, Amber KT. A systematic review of patients with mucocutaneous and respiratory complications in paraneoplastic autoimmune multiorgan syndrome: Castleman’s disease is the predominant malignancy. Lung. 2015;193(4):593–6.PubMedCrossRefPubMedCentralGoogle Scholar
  70. Leonard GD, Wright MA, Quinn MG, Fioravanti S, Harold N, Schuler B, Thomas RR, Grem JL. Survey of oxaliplatin-associated neurotoxicity using an interview-based questionnaire in patients with metastatic colorectal cancer. BMC Cancer. 2005;5:116.PubMedPubMedCentralCrossRefGoogle Scholar
  71. Levine JD, Reichling DB. Peripheral mechanisms of inflammatory pain. In: Wall PD, Melzack R, editors. Textbook of pain. 4th ed. London: Churchill Livingstone; 1999. p. 59–84.Google Scholar
  72. Littlewood T, Mandelli F. The effects of anemia in hematologic malignancies: more than a symptom. Semin Oncol. 2002;29(3, suppl 8):40–4.PubMedCrossRefPubMedCentralGoogle Scholar
  73. Lo Russo L, Fierro G, Guiglia R, Compilato D, Testa NF, Lo Muzio L, Campisi G. Epidemiology of desquamative gingivitis: evaluation of 125 patients and review of the literature. Int J Dermatol. 2009;48(10):1049–52.PubMedCrossRefPubMedCentralGoogle Scholar
  74. López-Jornet P, Camacho-Alonso F. Quality of life in patients with oral lichen planus. J Eval Clin Pract. 2010;16(1):111–3.PubMedCrossRefPubMedCentralGoogle Scholar
  75. Lossos A, Siegal T. Numb chin syndrome in cancer patients: etiology, response to treatment, and prognostic significance. Neurology. 1992;42(6):1181–4.PubMedCrossRefPubMedCentralGoogle Scholar
  76. Lozada-Nur F, Miranda C. Oral lichen planus: topical and systemic therapy. Semin Cutan Med Surg. 1997;16(4):295–300.PubMedCrossRefPubMedCentralGoogle Scholar
  77. Mackie AM, Epstein JB, JS W, Stevenson-Moore P. Nasopharyngeal carcinoma: the role of the dentist in assessment, early diagnosis and care before and after cancer therapy. Oral Oncol. 2000;36(5):397–403.PubMedCrossRefPubMedCentralGoogle Scholar
  78. Macquart-Moulin G, Viens P, Palangie T, Bouscary ML, Delozier T, Roche H, Janvier M, Fabbro M, Moatti JP. High-dose sequential chemotherapy with recombinant granulocyte colony stimulating factor and repeated stem-cell support for inflammatory breast cancer patients: does impact on quality of life jeopardize feasibility and acceptability of treatment? J Clin Oncol. 2000;18:754–64.PubMedCrossRefPubMedCentralGoogle Scholar
  79. Mantyh P. Bone cancer pain: causes, consequences, and therapeutic opportunities. Pain. 2013;154(Suppl 1):S54–62.PubMedCrossRefPubMedCentralGoogle Scholar
  80. Mantyh PW, Clohisy DR, Koltzenburg M, Hunt SP. Molecular mechanisms of cancer pain. Nat Rev Cancer. 2002;2(3):201–9.PubMedCrossRefPubMedCentralGoogle Scholar
  81. Marruecos J, Conill C, Valduvieco I, Vargas M, Berenguer J, Maurel J. Occipital condyle syndrome secondary to bone metastases from rectal cancer. Clin Transl Oncol. 2008;10(1):58–60.PubMedCrossRefPubMedCentralGoogle Scholar
  82. Mashu S, Shibaji T, Zeredo JL, Toda K, Suzuki N. Comparison of mechanical pain thresholds among various orofacial areas in human. Pain Research. 2004;19:123–31.CrossRefGoogle Scholar
  83. McCarthy GM, Skillings JR. Jaw and other orofacial pain in patients receiving vincristine for the treatment of cancer. Oral Surg Oral Med Oral Pathol. 1992;74:299–304.PubMedCrossRefPubMedCentralGoogle Scholar
  84. Meier JK, Wolff D, Pavletic S, Greinix H, Gosau M, Bertz H, Lee SJ, Lawitschka A, Elad S. Oral chronic graft-versus-host disease: report from the International Consensus Conference on clinical practice in cGVHD. Clin Oral Investig. 2011;15(2):127–39.PubMedCrossRefPubMedCentralGoogle Scholar
  85. Miaskowski C. Biology of mucosal pain. J Natl Cancer Inst Monogr. 2001;29:37–40.CrossRefGoogle Scholar
  86. Moazzam AA, Habibian M. Patients appearing to dental professionals with orofacial pain arising from intracranial tumors: a literature review. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012;114(6):749–55.PubMedCrossRefPubMedCentralGoogle Scholar
  87. Moeller JJ, Shivakumar S, Davis M, Maxner CE. Occipital condyle syndrome as the first sign of metastatic cancer. Can J Neurol Sci. 2007;34(4):456–9.PubMedCrossRefPubMedCentralGoogle Scholar
  88. Mravak-Stipetić M. Differential diagnostics of painful conditions of oral mucosa. Medical. Sciences. 2010;34:55–73.Google Scholar
  89. Mustafa MB, Arduino PG, Porter SR. Varicella zoster virus: review of its management. J Oral Pathol Med. 2009;38(9):673–88.PubMedCrossRefPubMedCentralGoogle Scholar
  90. Nasatzky E, Katz J, Hassharon H. Bell’s palsy associated with Herpes simplex gingivostomatitis. A case report. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998;86:293–6.PubMedCrossRefPubMedCentralGoogle Scholar
  91. Navarro M, Conde A, Gómez JC, Alañá M, Cruz JJ, Pascual J. Severe, unilateral facial pain as the presenting manifestation of lung cancer. Eur J Cancer Care (Engl). 2010;19(5):e10.CrossRefGoogle Scholar
  92. Ni Riordain R, Meaney S, McCreary C. Impact of chronic oral mucosal disease on daily life: preliminary observations from a qualitative study. Oral Dis. 2011a;17(3):265–9.PubMedCrossRefPubMedCentralGoogle Scholar
  93. Ni Riordain R, McCreary C. Validity and reliability of a newly developed quality of life questionnaire for patients with chronic oral mucosal diseases. J Oral Pathol Med. 2011b;40(8):604–9.PubMedCrossRefPubMedCentralGoogle Scholar
  94. Ni Riordain R, Shirlaw P, Alajbeg I, Al Zamel GY, Fung PL, Yuan AD, McCreary C, Stoopler ET, De Rossi SS, Lodi G, Greenberg MS, Brennan MT. World workshop on oral medicine VI: patient-reported outcome measures and oral mucosal disease: current status and future direction. Oral Surg Oral Med Oral Pathol Oral Radiol. 2015;120(2):152–60.CrossRefGoogle Scholar
  95. Ni Riordain R, Hodgson T, Porter S, Fedele S. Validity and reliability of the chronic oral mucosal diseases questionnaire in a UK population. J Oral Pathol Med. 2016;45(8):613–6.PubMedCrossRefPubMedCentralGoogle Scholar
  96. Nijs J, Leysen L, Adriaenssens N, Aguilar Ferrándiz ME, Devoogdt N, Tassenoy A, Ickmans K, Goubert D, van Wilgen CP, Wijma AJ, Kuppens K, Hoelen W, Hoelen A, Moloney N, Meeus M. Pain following cancer treatment: guidelines for the clinical classification of predominant neuropathic, nociceptive and central sensitization pain. Acta Oncol. 2016;55(6):659–63.PubMedCrossRefPubMedCentralGoogle Scholar
  97. Nikitakis NG, Sarlani E, Kolokythas A, Scheper MA, Kamperos G, Ord RA, Sklavounou-Andrikopoulou A. Frequency of pain and correlation with clinical and histologic parameters in T1 squamous cell carcinoma of the tongue: a retrospective pilot study. J Oral Facial Pain Headache. 2014;28(1):46–51.PubMedCrossRefPubMedCentralGoogle Scholar
  98. Palmieri A. Lung cancer presenting with unilateral facial pain: remission after laryngeal nerve palsy. Headache. 2006;46(5):813–5.PubMedCrossRefPubMedCentralGoogle Scholar
  99. Pankhurst CL. Oral mucositis(oropharyngeal). BMJ Clin Evid. 2013;2013:1304.PubMedPubMedCentralGoogle Scholar
  100. Pembroke CA, Byrne A, Lester JF, Button M. Persistent unilateral facial pain in lung cancer patients with mediastinal nodal involvement. Lung Cancer. 2013;82(1):173–5.PubMedCrossRefPubMedCentralGoogle Scholar
  101. Pergolizzi JV, Gharibo C, Ho KY. Treatment considerations for cancer pain: a global perspective. Pain Pract. 2015;15(8):778–92.PubMedCrossRefPubMedCentralGoogle Scholar
  102. Portenoy RK, Lesage P. Management of cancer pain. Lancet. 1999;353(9165):1695–700.PubMedCrossRefPubMedCentralGoogle Scholar
  103. Porter SR, Scully C, Pedersen A. Recurrent aphthous stomatitis. Crit Rev Oral Biol Med. 1998;9(3):306–21.PubMedCrossRefPubMedCentralGoogle Scholar
  104. Preeti L, Magesh K, Rajkumar K, Karthik R. Recurrent aphthous stomatitis. J Oral and Maxillofac Pathol. 2011;15(3):252–6.CrossRefGoogle Scholar
  105. Ramírez-Amador V, Anaya-Saavedra G, Crespo-Solís E, Camacho EI, González-Ramírez I, Ponce-de-León S. Prospective evaluation of oral mucositis in acute leukemia patients receiving chemotherapy. Support Care Cancer. 2010;18(5):639–46.PubMedCrossRefPubMedCentralGoogle Scholar
  106. Reddi D, Curran N. Chronic pain after surgery: pathophysiology, risk factors and prevention. Postgrad Med J. 2014;90(1062):222–7.PubMedCrossRefPubMedCentralGoogle Scholar
  107. Reddy GD, Wagner K, Phan J, DeMonte F, Raza SM. Management of skull base tumor-associated facial pain. Neurosurg Clin N Am. 2016;27(3):337–44.PubMedCrossRefPubMedCentralGoogle Scholar
  108. Reyes-Gibby CC, Anderson KO, Merriman KW, Todd KH, Shete SS, Hanna EY. Survival patterns in squamous cell carcinoma of the head and neck: pain as an independent prognostic factor for survival. J Pain. 2014;15(10):1015–22.PubMedPubMedCentralCrossRefGoogle Scholar
  109. Ripamonti CI, Santini D, Maranzano E, Berti M, Roila F. ESMO guidelines working group. Management of cancer pain: ESMO Clinical Practice Guidelines. Ann Oncol. 2012;23(Suppl 7):vii139–54.PubMedCrossRefPubMedCentralGoogle Scholar
  110. Rogers RS. Recurrent aphthous stomatitis: clinical characteristics and associated systemic disorders. Semin Cutan Med Surg. 1997;16(4):278–83.PubMedCrossRefPubMedCentralGoogle Scholar
  111. Rogríguez D, Urrutia G, Escobar Y, Moya J, Murillo M. Efficacy and safety of oral or nasal fentanyl for treatment of breakthrough pain in cancer patients: a systematic review. J Pain Palliat Care Pharmacother. 2015;29(3):228–46.PubMedCrossRefPubMedCentralGoogle Scholar
  112. Rose-Ped AM, Bellm LA, Epstein JB, Trotti A, Gwede C, Fuchs HJ. Complications of radiation therapy for head and neck cancers. The patient's perspective. Cancer Nurs. 2002;25(6):461–7.PubMedCrossRefPubMedCentralGoogle Scholar
  113. Ruffatti S, Zanchin G, Maggioni F. A case of intractable facial pain secondary to metastatic lung cancer. Neurol Sci. 2008;29(2):117–9.PubMedCrossRefPubMedCentralGoogle Scholar
  114. Sarlani E, Schwartz AH, Greenspan JD, Grace EG. Facial pain as first manifestation of lung cancer: a case of lung cancer-related cluster headache and a review of the literature. J Orofac Pain. 2003;17(3):262–7.PubMedPubMedCentralGoogle Scholar
  115. Sato J, Yamazaki Y, Satoh A, Notani K, Kitagawa Y. Pain is associated with an endophytic cancer growth pattern in patients with oral squamous cell carcinoma before treatment. Odontology. 2010;98(1):60–4.PubMedCrossRefPubMedCentralGoogle Scholar
  116. Sato J, Yamazaki Y, Satoh A, Onodera-Kyan M, Abe T, Satoh T, Notani K, Kitagawa Y. Pain may predict poor prognosis in patients with oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011;111(5):587–92.PubMedCrossRefPubMedCentralGoogle Scholar
  117. Saunders DP, Epstein JB, Elad S, Allemano J, Bossi P, van de Wetering MD, Rao NG, Potting C, Cheng KK, Freidank A, Brennan MT, Bowen J, Dennis K, Lalla RV. Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO). Systematic review of antimicrobials, mucosal coating agents, anesthetics, and analgesics for the management of oral mucositis in cancer patients. Support Care Cancer. 2013;21(11):3191–207.PubMedCrossRefPubMedCentralGoogle Scholar
  118. Schmidt BL. The neurobiology of cancer pain. Neuroscientist. 2014;20(5):546–62.PubMedPubMedCentralCrossRefGoogle Scholar
  119. Schmidt BL. The neurobiology of cancer pain. J Oral Maxillofac Surg. 2015;73(12 Suppl):S132–5.PubMedPubMedCentralCrossRefGoogle Scholar
  120. Schubert MM, Correa ME. Oral graft-versus-host disease. Dent Clin N Am. 2008;52(1):79–109.PubMedCrossRefPubMedCentralGoogle Scholar
  121. Schubert MM, Sullivan KM, Morton TH, Izutsu KT, Peterson DE, Flournoy N, Truelove EL, Sale GE, Buckner CD, Storb R, et al. Oral manifestations of chronic graft-v-host disease. Arch Intern Med. 1984;144(8):1591–5.PubMedCrossRefPubMedCentralGoogle Scholar
  122. Scully C. Sensory and motor changes and taste abnormalities. In: Oral and maxillofacial medicine, 119–30. 2nd ed. Edinburgh: Elsevier; 2008.Google Scholar
  123. Sharav Y, Benoliel R. Orifacial pain and headache. 2nd ed. Chicago: Quintessence; 2015.Google Scholar
  124. Singer S, Langendijk J, Yarom N. Assessing and improving quality of life in patients with head and neck cancer. Am Soc Clin Oncol Educ Book 2013.  https://doi.org/10.1200/EdBook_AM.2013.33.e230.CrossRefGoogle Scholar
  125. Su CY, Lui CC. Perineural invasion of the trigeminal nerve in patients with nasopharyngeal carcinoma. Imaging and clinical correlations. Cancer. 1996;78(10):2063–9.PubMedCrossRefPubMedCentralGoogle Scholar
  126. Tappuni AR, Kovacevic T, Shirlaw PJ, Challacombe SJ. Clinical assessment of disease severity in recurrent aphthous stomatitis. J Oral Pathol Med. 2013;42:635–41.PubMedCrossRefPubMedCentralGoogle Scholar
  127. Toda K, Ishii N, Nakamura Y. Characteristics of mucosal nociceptors in the rat oral cavity: an in vitro study. Neurosci Lett. 1997;228:95–8.PubMedCrossRefPubMedCentralGoogle Scholar
  128. Treister NS, Cook EF Jr, Antin J, Lee SJ, Soiffer R, Woo SB. Clinical evaluation of oral chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2008;14(1):110–5.PubMedCrossRefPubMedCentralGoogle Scholar
  129. Treister N, Chai X, Kurland B, Pavletic S, Weisdorf D, Pidala J, Palmer J, Martin P, Inamoto Y, Arora M, Flowers M, Jacobsohn D, Jagasia M, Arai S, Lee SJ, Cutler C. Measurement of oral chronic GVHD: results from the chronic GVHD consortium. Bone Marrow Transplant. 2013;48(8):1123–8.PubMedPubMedCentralCrossRefGoogle Scholar
  130. Van Abel KM, Starkman S, O’Reilly AG, Price DL. Craniofacial pain secondary to occult head and neck tumors. Otolaryngol Head Neck Surg. 2014;150(5):813–7.PubMedCrossRefPubMedCentralGoogle Scholar
  131. van den Beuken-van Everdingen MH, de Rijke JM, Kessels AG, Schouten HC, van Kleef M, Patijn J. Prevalence of pain in patients with cancer: a systematic review of the past 40 years. Ann Oncol. 2007;18(9):1437–49.PubMedCrossRefPubMedCentralGoogle Scholar
  132. van den Beuken-van Everdingen MH, Hochstenbach LM, Joosten EA, Tjan-Heijnen VC, Janssen DJ. Update on prevalence of pain in patients with cancer: systematic review and meta-analysis. J Pain Symptom Manag. 2016;51(6):1070–90.CrossRefGoogle Scholar
  133. Viet CT, Schmidt BL. Biologic mechanisms of oral cancer pain and implications for clinical therapy. J Dent Res. 2012;91(5):447–53.PubMedPubMedCentralCrossRefGoogle Scholar
  134. Viet CT, Corby PM, Akinwande A, Schmidt BL. Review of preclinical studies on treatment of mucositis and associated pain. J Dent Res. 2014;93(9):868–75.PubMedPubMedCentralCrossRefGoogle Scholar
  135. Villa A, Aboalela A, Luskin KA, Cutler CS, Sonis ST, Woo SB, Peterson DE, Treister NS. Mammalian target of rapamycin inhibitor-associated stomatitis in hematopoietic stem cell transplantation patients receiving sirolimus prophylaxis for graft-versus-host disease. Biol Blood Marrow Transplant. 2015;21(3):503–8.PubMedCrossRefPubMedCentralGoogle Scholar
  136. Webb BC, Thomas CJ, Willcox MD, Harty DW, Knox KW. Candida-associated denture stomatitis. Aetiology and management: a review. Part 3. Treatment of oral candidosis. Aust Dent J. 1998;43(4):244–9.PubMedCrossRefPubMedCentralGoogle Scholar
  137. Yarom N, Yahalom R, Shoshani Y, Hamed W, Regev E, Elad S. Osteonecrosis of the jaw induced by orally administered bisphosphonates: incidence, clinical features, predisposing factors and treatment outcome. Osteoporos Int. 2007;18(10):1363–70.PubMedCrossRefPubMedCentralGoogle Scholar
  138. Yarom N, Elad S, Madrid C, Migliorati CA. Osteonecrosis of the jaws induced by drugs other than bisphosphonates – a call to update terminology in light of new data. Oral Oncol. 2010a;46(1):e1.PubMedCrossRefPubMedCentralGoogle Scholar
  139. Yarom N, Fedele S, Lazarovici TS, Elad S. Is exposure of the jawbone mandatory for establishing the diagnosis of bisphosphonate-related osteonecrosis of the jaw? J Oral Maxillofac Surg. 2010b;68(3):705.PubMedCrossRefPubMedCentralGoogle Scholar
  140. Yarom N, Lazarovici TS, Elad S. Oral bisphosphonate-related osteonecrosis of the jaw: incidence, clinical features, prevention, and treatment recommendations. Clinic Rev Bone Miner Metab. 2010c;8(1):27–31.CrossRefGoogle Scholar
  141. Yura Y, Kusaka J, Yamakawa R, Bando T, Yoshida H, Sato M. Mental nerve neuropathy as a result of primary herpes simplex virus infection in the oral cavity. A case report. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000;90:306–9.PubMedCrossRefPubMedCentralGoogle Scholar
  142. Zadik Y, Vainstein V, Heling I, Neuman T, Drucker S, Elad S. Cytotoxic chemotherapy-induced odontalgia: a differential diagnosis for dental pain. J Endod. 2010;36:1588–92.PubMedCrossRefPubMedCentralGoogle Scholar
  143. Zadik Y, Benoliel R, Fleissig Y, Casap N. Painful trigeminal neuropathy induced by oral bisphosphonate-related osteonecrosis of the jaw: a new etiology for the numb-chin syndrome. Quintessence Int. 2012a;43(2):97–104.PubMedPubMedCentralGoogle Scholar
  144. Zadik Y, Yarom N, Elad S. Orofacial neuropathy and pain in cancer patients. In: Raffa RB, Langford R, Pergolizzi Jr JV, Porreca F, Tallarida RJ, editors. Chemotherapy-induced neuropathic pain. 1st ed. Boca Raton: CRC Press; 2012b.Google Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Oral Medicine UnitSheba Medical CenterTel HashomerIsrael
  2. 2.Department of Oral Pathology and Oral Medicine, School of Dental MedicineTel-Aviv UniversityTel-AvivIsrael
  3. 3.Division of Oral Medicine and DentistryBrigham and Women’s HospitalBostonUSA
  4. 4.Department of Oral Medicine, Eastman Institute for Oral MedicineUniversity of Rochester Medical CenterRochesterUSA

Personalised recommendations